Integrity:
Steadfast adherence to a strict moral and ethical code. The foundation of RxEDO’s fully transparent business model is based on integrity. RxEDO believes that if we act in the best interest of our clients and industry partners, we will all be rewarded. Specifically, our clients and partners receive the service they expect at the best possible price, while at the same time having the peace of mind that RxEDO’s business model is in line with their objectives.
[Next]
RxEDO is a PBM-Alternative company, a Prescription Benefit Partner (PBP), which details and fully discloses for its clients all revenue sources related to processing prescription drug claims. In addition to claims processing and support, RxEDO provides clinical, consultative, and educational support which empowers and enables clients to manage their drug spend more efficiently. RxEDO clients are able to determine the true cost of their prescription benefit services.
RxEDO’s straight forward business approach is based on the principle of doing what is right for the client. RxEDO makes it easier for clients to determine their prescription benefit administrative cost by charging a flat per claim transaction processing fee. This approach eliminates the guessing game created by the PBM industry in regards to quantifying their true prescription drug and administrative cost.
Ultimately, RxEDO asks clients to rethink their current PBM relationship, reevaluate their current PBMs performance and, most importantly, to redefine their expectations regarding their prescription drug benefit.
PBM Industry Forecast
Most analysts agree that the PBM industry must undergo some major changes in order to regain the confidence of employers, health plans, and other payers that PBMs enjoyed in the past. Healthcare consumers are becoming more educated and more sophisticated, and they will demand transparency and full disclosure of their PBM's revenue sources. We feel RxEDO's business model will expedite this change within the industry.